Location History:
- Ile Bizard, CA (2015)
- Ile Bizzard, CA (2016 - 2019)
- Québec, CA (2019)
- Montreal, CA (2023)
- Boucherville, CA (2013 - 2024)
Company Filing History:
Years Active: 2013-2024
Title: Pierre Thibault: Innovator in Plasma Technology and Tumor Immunology
Introduction
Pierre Thibault is a distinguished inventor based in Ile-Bizard, Canada. He holds a total of seven patents, showcasing his innovative contributions to the fields of plasma technology and tumor immunology. His work has significantly advanced the understanding and application of electrodeless devices and cancer treatment methodologies.
Latest Patents
One of Thibault's latest patents is the "Electrodeless Plasma Device." This invention features a closed loop tubular discharge assembly designed for an electrodeless light-emitting device and discharge reactor. The assembly consists of one or more tubular segments that are connected at their ends, forming a hermetically sealed loop that encloses an ionizable gas. Notably, at least one segment is a non-cylindrical, hollow-shaped tubular segment, which enhances performance compared to prior art devices. Another significant patent is the "Proteogenomic-Based Method for Identifying Tumor-Specific Antigens." This method utilizes RNA-sequencing data to identify tumor-specific antigens that are crucial for the recognition and eradication of tumor cells by CD8 T cells. This innovative approach works effectively regardless of the sample's mutational load or complexity.
Career Highlights
Throughout his career, Thibault has made substantial contributions to research and development in his fields of expertise. His innovative patents reflect his commitment to advancing technology and improving cancer treatment methodologies.
Collaborations
Thibault has collaborated with notable individuals such as Sébastien Lemieux and Claude Perreault. These collaborations have further enriched his research and development efforts.
Conclusion
Pierre Thibault is a prominent inventor whose work in plasma technology and tumor immunology has made a significant impact. His innovative patents and collaborations highlight his dedication to advancing scientific knowledge and improving healthcare solutions.